Polio Virus - UCSF Office of Research
... infections are asymptomatic. Symptomatic cases are characterized by two phases—first a non specific febrile illness followed by (in a small percentage of cases) aseptic meningitis or paralytic disease. The ratio of cases of inapparent infection to paralytic disease ranges from 100:1 to 1,000:1. Afte ...
... infections are asymptomatic. Symptomatic cases are characterized by two phases—first a non specific febrile illness followed by (in a small percentage of cases) aseptic meningitis or paralytic disease. The ratio of cases of inapparent infection to paralytic disease ranges from 100:1 to 1,000:1. Afte ...
The CDC says that there is not a limit on how many vaccines the
... hopefully children aren’t getting too many pokes at one time. ...
... hopefully children aren’t getting too many pokes at one time. ...
risk of infection east and southwest asia
... infection is asymptomatic. Rarely, the infection produces minor symptoms; these may include upper respiratory tract infection (sore throat and fever), gastrointestinal disturbances (nausea, vomiting, abdominal pain, constipation or, rarely, diarrhea), and influenza-like illness. The virus enters the ...
... infection is asymptomatic. Rarely, the infection produces minor symptoms; these may include upper respiratory tract infection (sore throat and fever), gastrointestinal disturbances (nausea, vomiting, abdominal pain, constipation or, rarely, diarrhea), and influenza-like illness. The virus enters the ...
Rotavirus
... •Has been at the root of several epidemics or outbreaks of gastroenteritis across North America in hospital emergency rooms, schools and even on cruise ships •There is a group of similar or related viruses that are referred to as Norwalk-like viruses or agents. •Can infect people of any age and usua ...
... •Has been at the root of several epidemics or outbreaks of gastroenteritis across North America in hospital emergency rooms, schools and even on cruise ships •There is a group of similar or related viruses that are referred to as Norwalk-like viruses or agents. •Can infect people of any age and usua ...
Poliomyelitis vaccines for Australians - fact sheet
... symptoms shed the virus in their stools and, therefore, are able to transmit the virus to others. In polio endemic areas, persons with asymptomatic infections, particularly children, act as the main reservoir of polio infection.1,2 Rarely (in less than 1% of polio infections), the virus invades and ...
... symptoms shed the virus in their stools and, therefore, are able to transmit the virus to others. In polio endemic areas, persons with asymptomatic infections, particularly children, act as the main reservoir of polio infection.1,2 Rarely (in less than 1% of polio infections), the virus invades and ...
Case for LU#4. Mysterious paralysis
... “Like a polio ward from the 1950s” is how Guy McKhann, MD, neurologist, describes a section of Beijing Hospital that he visited on a trip to China in 1986. Dozens of paralyzed children – some attached to respirators to assist their breathing – filled the ward to overflowing. The Chinese doctors thou ...
... “Like a polio ward from the 1950s” is how Guy McKhann, MD, neurologist, describes a section of Beijing Hospital that he visited on a trip to China in 1986. Dozens of paralyzed children – some attached to respirators to assist their breathing – filled the ward to overflowing. The Chinese doctors thou ...
Disease and Contemporary Society
... As the lecture series deals with current topics there are no books dealing directly with much of the course material. These books are easy to read and provide background. ...
... As the lecture series deals with current topics there are no books dealing directly with much of the course material. These books are easy to read and provide background. ...
Acute Flaccid Paralysis (AFP) - Leeds, Grenville and Lanark District
... onset weakness, which may include respiratory and bulbar weakness. AFP is a broad clinical syndrome with an array of diagnostic possibilities, and may be the result of infectious or non-infectious agents. Surveillance is conducted in an attempt to identify cases of AFP and to investigate all reporte ...
... onset weakness, which may include respiratory and bulbar weakness. AFP is a broad clinical syndrome with an array of diagnostic possibilities, and may be the result of infectious or non-infectious agents. Surveillance is conducted in an attempt to identify cases of AFP and to investigate all reporte ...
Section 4 Immunization
... influenza are pneumonia, middle ear infection, heart failure and possible death. The influenza virus is highly contagious and spreads through respiratory secretions. The influenza vaccine changes yearly so it is important to receive you immunization at the beginning of every influenza season. Varice ...
... influenza are pneumonia, middle ear infection, heart failure and possible death. The influenza virus is highly contagious and spreads through respiratory secretions. The influenza vaccine changes yearly so it is important to receive you immunization at the beginning of every influenza season. Varice ...
Elisa kits Manual - Alpha Diagnostic International
... POLV14-M Mouse monoclonal Anti-Poliomyelitis Virus 1 IgG, aff pure POLV15-R-10 Recombinant (E. Coli) Poliomyelitis Virus 1 Viral Protein 1 (Sabin; POLV1-VP1, 302-aa; full length, >95%) POLV15-S Anti-Poliomyelitis Virus 1 Viral Protein 1 (Sabin; POLV1-VP1) ...
... POLV14-M Mouse monoclonal Anti-Poliomyelitis Virus 1 IgG, aff pure POLV15-R-10 Recombinant (E. Coli) Poliomyelitis Virus 1 Viral Protein 1 (Sabin; POLV1-VP1, 302-aa; full length, >95%) POLV15-S Anti-Poliomyelitis Virus 1 Viral Protein 1 (Sabin; POLV1-VP1) ...
"Plus" in PolioPlus - My Rotary
... its spearheading partners: the World Health Organization (WHO), UNICEF, the U.S. Centers for Disease Control and Prevention (CDC), and, of course, Rotary International. A decade before the partners came together in 1988, Rotary had embarked on a project to immunize six million children in the Philip ...
... its spearheading partners: the World Health Organization (WHO), UNICEF, the U.S. Centers for Disease Control and Prevention (CDC), and, of course, Rotary International. A decade before the partners came together in 1988, Rotary had embarked on a project to immunize six million children in the Philip ...
Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Polio
... Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Polio, and Haemophilus Influenzae type b vaccine 1. What are Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio and Haemophilus Influenzae type b Diphtheria is caused by bacteria that infect the nose and throat. These bacteria release a p ...
... Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Polio, and Haemophilus Influenzae type b vaccine 1. What are Diphtheria, Tetanus, Pertussis, Hepatitis B, Polio and Haemophilus Influenzae type b Diphtheria is caused by bacteria that infect the nose and throat. These bacteria release a p ...
Endemic Diseases Involving Nervous System OBJECTIVES
... Weakness of voluntary muscles Flaccid paralysis of voluntary muscles, develops within the first few days. ...
... Weakness of voluntary muscles Flaccid paralysis of voluntary muscles, develops within the first few days. ...
read more
... What causes polio? Polio is caused by the poliovirus, a highly contagious virus specific to humans. The virus usually enters the environment in the feces of someone who is infected. In areas with poor sanitation, the virus easily spreads through the fecal-oral route, via contaminated water or food. ...
... What causes polio? Polio is caused by the poliovirus, a highly contagious virus specific to humans. The virus usually enters the environment in the feces of someone who is infected. In areas with poor sanitation, the virus easily spreads through the fecal-oral route, via contaminated water or food. ...
MenACWY Information Pack
... The MenACWY vaccine does not protect against all causes of meningitis and septicaemia ...
... The MenACWY vaccine does not protect against all causes of meningitis and septicaemia ...
ppt - Komion
... Rapid action 0-4 hours Non-specific – same response each time No memory – same response at each encounter • May destruct the antigen ...
... Rapid action 0-4 hours Non-specific – same response each time No memory – same response at each encounter • May destruct the antigen ...
Polio eradication and Endgame Strategic plan
... Global Polio Eradication Initiative (GPEI) AIMS TO WIPE OUT THE LAST CASES OF POLIO FROM ALL CAUSES BY 2018 ...
... Global Polio Eradication Initiative (GPEI) AIMS TO WIPE OUT THE LAST CASES OF POLIO FROM ALL CAUSES BY 2018 ...
Oops! Don`t Lose Your Footing!! - North Central Florida Post
... The first part of our March program for the NCFPPSG was presented by Dr. Bruce D. Woloksy, DPM, foot specialist. Dr. Wolosky departed from his past talks that focused strictly on the feet to offer us an overview of the history of poliomyelitis or infantile paralysis. The Good Doctor proved not only ...
... The first part of our March program for the NCFPPSG was presented by Dr. Bruce D. Woloksy, DPM, foot specialist. Dr. Wolosky departed from his past talks that focused strictly on the feet to offer us an overview of the history of poliomyelitis or infantile paralysis. The Good Doctor proved not only ...
TAKE CARE - East Perth Medical Centre
... sub-unit (inactivated) vaccines, which only contain the surface structures of the virus, rather than infectious particles. The incubation period for influenza is between 24–72 hours, and the vaccine takes 7–14 days to produce protection, so occasionally a vaccine recipient may contract the influenza ...
... sub-unit (inactivated) vaccines, which only contain the surface structures of the virus, rather than infectious particles. The incubation period for influenza is between 24–72 hours, and the vaccine takes 7–14 days to produce protection, so occasionally a vaccine recipient may contract the influenza ...
UNICEF`s engagement in the Global Polio Eradication Initiative
... • >US$ 8.2 billion international investment • Goal: A polio-free world Source: GPEI website www.polioeradication.org/AboutUs.aspx ...
... • >US$ 8.2 billion international investment • Goal: A polio-free world Source: GPEI website www.polioeradication.org/AboutUs.aspx ...
Poliomyelitis: Current Status in Iran and Worldwide
... infection is asymptomatic. Rarely, the infection produces minor symptoms; these may include upper respiratory tract infection (sore throat and fever), gastrointestinal disturbances (nausea, vomiting, abdominal pain, constipation or, rarely, diarrhea), and influenza-like illness(1). The virus enters ...
... infection is asymptomatic. Rarely, the infection produces minor symptoms; these may include upper respiratory tract infection (sore throat and fever), gastrointestinal disturbances (nausea, vomiting, abdominal pain, constipation or, rarely, diarrhea), and influenza-like illness(1). The virus enters ...
National Certification Committee for Polio Eradication
... National plans for responding to poliovirus importation Access to OPV & licensure of tOPV/bOPV/mOPV Countries with recent importation and circulation of WPV/cVDPV to survey & update laboratory inventories – NCC to review and improve quality of annual National ...
... National plans for responding to poliovirus importation Access to OPV & licensure of tOPV/bOPV/mOPV Countries with recent importation and circulation of WPV/cVDPV to survey & update laboratory inventories – NCC to review and improve quality of annual National ...
Potential for verification of conditions included in data linkage
... 1. To determine the incidence of AFP. 2. To determine whether AFP is caused by Polio virus infection and if so whether it is wild or vaccine strain Polio. 3. To determine other causes of AFP. 4. To determine the clinical picture of AFP, including outcome of non-polio AFP. CASE DEFINITION AND REPORTI ...
... 1. To determine the incidence of AFP. 2. To determine whether AFP is caused by Polio virus infection and if so whether it is wild or vaccine strain Polio. 3. To determine other causes of AFP. 4. To determine the clinical picture of AFP, including outcome of non-polio AFP. CASE DEFINITION AND REPORTI ...
Poliomyelitis
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.